JP2019523265A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523265A5
JP2019523265A5 JP2019503925A JP2019503925A JP2019523265A5 JP 2019523265 A5 JP2019523265 A5 JP 2019523265A5 JP 2019503925 A JP2019503925 A JP 2019503925A JP 2019503925 A JP2019503925 A JP 2019503925A JP 2019523265 A5 JP2019523265 A5 JP 2019523265A5
Authority
JP
Japan
Prior art keywords
pulmonary fibrosis
risk
subject
pharmaceutical composition
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503925A
Other languages
English (en)
Japanese (ja)
Other versions
JP6983222B2 (ja
JP2019523265A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2017/050784 external-priority patent/WO2018018091A1/en
Publication of JP2019523265A publication Critical patent/JP2019523265A/ja
Publication of JP2019523265A5 publication Critical patent/JP2019523265A5/ja
Application granted granted Critical
Publication of JP6983222B2 publication Critical patent/JP6983222B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503925A 2016-07-28 2017-07-28 肺線維症の処置のための組成物 Active JP6983222B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2016902978 2016-07-28
AU2016902978A AU2016902978A0 (en) 2016-07-28 Compositions for the treatment of pulmonary fibrosis
PCT/AU2017/050784 WO2018018091A1 (en) 2016-07-28 2017-07-28 Compositions for the treatment of pulmonary fibrosis

Publications (3)

Publication Number Publication Date
JP2019523265A JP2019523265A (ja) 2019-08-22
JP2019523265A5 true JP2019523265A5 (cg-RX-API-DMAC7.html) 2021-10-21
JP6983222B2 JP6983222B2 (ja) 2021-12-17

Family

ID=61015577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019503925A Active JP6983222B2 (ja) 2016-07-28 2017-07-28 肺線維症の処置のための組成物

Country Status (21)

Country Link
US (2) US10919863B2 (cg-RX-API-DMAC7.html)
EP (1) EP3490970B1 (cg-RX-API-DMAC7.html)
JP (1) JP6983222B2 (cg-RX-API-DMAC7.html)
KR (1) KR102377981B1 (cg-RX-API-DMAC7.html)
CN (1) CN109661387B (cg-RX-API-DMAC7.html)
AU (1) AU2017301113B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019001510B1 (cg-RX-API-DMAC7.html)
CA (1) CA3030309C (cg-RX-API-DMAC7.html)
DK (1) DK3490970T3 (cg-RX-API-DMAC7.html)
ES (1) ES2965041T3 (cg-RX-API-DMAC7.html)
FI (1) FI3490970T3 (cg-RX-API-DMAC7.html)
IL (1) IL264392B2 (cg-RX-API-DMAC7.html)
MX (1) MX393490B (cg-RX-API-DMAC7.html)
MY (1) MY192402A (cg-RX-API-DMAC7.html)
NZ (1) NZ750495A (cg-RX-API-DMAC7.html)
PH (1) PH12019500180A1 (cg-RX-API-DMAC7.html)
RU (1) RU2747801C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201900182PA (cg-RX-API-DMAC7.html)
UA (1) UA124468C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018018091A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201901099B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ736165A (en) * 2015-03-18 2022-07-01 Vectus Biosystems Ltd Compositions for the treatment of kidney and/or liver disease
BR112019001510B1 (pt) * 2016-07-28 2022-11-08 Vectus Biosystems Limited Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar
ES3067250A1 (es) * 2024-11-08 2026-05-20 Univ Valencia Tratamiento del Síndrome de Dificultad Respiratoria Aguda (SDRA) con inhibidores de GPBP1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368865B (es) * 2013-09-17 2019-08-02 Vectus Biosystems Ltd Composiciones para el tratamiento de hipertension y/o fibrosis.
US9630935B2 (en) 2013-09-17 2017-04-25 Vectus Biosystems Limited Compositions for the treatment of hypertension and/or fibrosis
JP6454348B2 (ja) * 2013-12-19 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 窒素複素環誘導体およびその医薬品への応用
WO2016046782A1 (en) * 2014-09-26 2016-03-31 Glenmark Pharmaceuticals S.A. Imidazole biaryl compounds as s-nitrosoglutathione reductase inhibitors
WO2016107906A1 (en) * 2014-12-31 2016-07-07 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition
SG11201707561RA (en) * 2015-03-18 2017-10-30 Vectus Biosystems Ltd Compositions for the treatment of fibrosis and fibrosis-related conditions
NZ736165A (en) * 2015-03-18 2022-07-01 Vectus Biosystems Ltd Compositions for the treatment of kidney and/or liver disease
EP3353147B1 (en) * 2015-09-22 2021-01-13 Vectus Biosystems Limited Synthesis of terphenyl compounds
BR112019001510B1 (pt) * 2016-07-28 2022-11-08 Vectus Biosystems Limited Composto, e, uso de um composto para manufatura de um medicamento para tratar profilática ou terapeuticamente fibrose pulmonar, ou uma enfermidade relacionada em um indivíduo com fibrose pulmonar ou em risco de desenvolver fibrose pulmonar

Similar Documents

Publication Publication Date Title
JP2020500862A5 (cg-RX-API-DMAC7.html)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2022510313A5 (cg-RX-API-DMAC7.html)
CN111989332A (zh) 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用
JP2020514316A5 (cg-RX-API-DMAC7.html)
JP2019014758A5 (cg-RX-API-DMAC7.html)
JP2022506111A5 (cg-RX-API-DMAC7.html)
JP2020536888A5 (cg-RX-API-DMAC7.html)
JP2020505405A5 (cg-RX-API-DMAC7.html)
JP2015505301A5 (cg-RX-API-DMAC7.html)
JP2010501003A5 (cg-RX-API-DMAC7.html)
RU2009102278A (ru) Модуляторы рецептора s1p для лечения рассеянного склероза
JP2015537020A5 (cg-RX-API-DMAC7.html)
RU2013140169A (ru) Противоопухолевое терапевтическое средство
JP2020533352A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
EA006154B1 (ru) N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов при fsad
JP2017510595A5 (cg-RX-API-DMAC7.html)
RU2011106364A (ru) Жидкие составы
JP2022512736A5 (cg-RX-API-DMAC7.html)
JP2021528386A5 (cg-RX-API-DMAC7.html)
JP2015051983A5 (cg-RX-API-DMAC7.html)
JP2019535723A5 (cg-RX-API-DMAC7.html)
JP2011504903A5 (cg-RX-API-DMAC7.html)
JP2022544536A5 (cg-RX-API-DMAC7.html)